Impact BioMedical (IBO)

• Market cap: $67.8M
• 1 day: 0.3%
• 5 days: 4.83%
• 1 month: -11.41%
• 3 months: 39.5%
• 6 months: 12.4%
• Year to date: 21.31%
• 1 year: 26.43%
• 5 years: -76.53%
• 10 years: -76.53%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.

Employees: 8